Carvedilol
Product Images NDC 52959-466

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 52959-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (Carvediloltablets Figure 01)

Chemical structure of Carvedilol, depicting its molecular arrangement including benzene rings and functional groups such as hydroxyl and methoxy substituents as part of its complex organic structure.*

FDA Label Image

Structured Formula For Carvedilol (Carvediloltablets Figure 02)

A Kaplan-Meier survival curve comparing mortality percentages over 24 months between Carvedilol and placebo. The y-axis represents percentage mortality from 0 to 30%, and the x-axis shows time in months. The Carvedilol group shows lower mortality than placebo, with a reported P-value of 0.03 indicating statistical significance.*

FDA Label Image

Structured Formula For Carvedilol (Carvediloltablets Figure 03)

A forest plot depicting hazard ratios for different patient subgroups and conditions related to myocardial infarction (MI) and heart failure (CHF). The horizontal axis shows hazard ratios ranging approximately from 0.4 to 1.3. Various factors such as age, gender, timing post-MI, prior use of beta blockers, Killip class, thrombolytic use, PCI for MI, presence of CHF, diuretics use, angina, hypertension, diabetes, heart rate, and systolic blood pressure are listed alongside corresponding hazard ratio points and confidence intervals.*

FDA Label Image

Structured Formula For Carvedilol (Carvediloltablets Figure 05)

Carvedilol 6.25 mg tablet label showing product NDC 52959-466-30 by H.J. Harkins Company, Inc. The label indicates a lot number CVL600ZY, manufacture by Zydus in India, expiration date 09/12, and notes to compare to Coreg (NDC 68382-093-05). Directions advise to take as directed by a doctor with usual dosage information on the outer packaging. The label includes regulatory warnings and repackaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.